Patent · US Active

Genetically modified non-human animal with human or chimeric genes

US11154041B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignees

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN
Biocytogen JiangSu Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Yanan Guo · Beijing, CN
Yang Bai · Beijing, CN
Rui Huang · Beijing, CN
Xiaofei Zhou · Beijing, CN
Chengzhang Shang · Beijing, CN
Meiling Zhang · Beijing, CN
Jiawei Yao · Beijing, CN
Chaoshe Guo · Beijing, CN

Key dates

Filing date	Sep 2, 2020
Grant date	Oct 26, 2021
Priority date	—
Expiry date	Sep 2, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/20
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) IL4R and/or IL4, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.